drugset / Trial / NCT03777878
Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Purpose to evaluates the effects of oxytocin infusion with or without intravenous tranexamic acid (TA) in comparison with Carbetocin for prevention of postpartum hemorrhage at a cesarean section with one or more risk factor for postpartum hemorrhage.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2021-03-30
- Completion
- 2021-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | Oxytocin | Peptide | 20 iu | Intravenous |
| Comparator | Tranexamic Acid | Small molecule | 1 g | Intravenous |
Indications
No indication recorded.